MINIEYE (02431): Executive Director and Chairman Liu Guoqing increases holdings by 100,000 shares of the company's H shares.
YouJia Innovation (02431) announced that the Board of Directors was informed by the Company's Executive Director, General Manager, and Chairman of the Board, Dr. Liu Guoqing, that he purchased a total of 100,000 H shares of the Company on the open market on September 8, 2026, at an average price of approximately HK$2.5272 per share, representing about 0.02% of the total number of issued shares of the Company. Immediately after the purchase, as of the date of this announcement, Dr. Liu holds beneficial interests in a total of 34.6835 million shares, accounting for approximately 7.8% of the Company's total issued share capital, and together with his concert parties (including the Company's Executive Directors Mr. Yang Guang, Mr. Zhou Xiang, and Mr. Wang Qicheng), they collectively hold about 17.57% of the Company's total issued share capital.
MINIEYE (02431) announced that the board of directors was informed by Dr. Liu Guoqing, the company's executive director, general manager, and chairman of the board, that he purchased a total of 100,000 H shares of the company on the open market on September 8, 2026, at an average price of approximately HKD 2.5272 per H share, accounting for about 0.02% of the company's total issued shares. Following this purchase, as of the date of this announcement, Dr. Liu holds beneficial interests in a total of 34.6835 million shares, representing approximately 7.8% of the company's total issued capital. Together with his concert parties (including the company's executive directors, Mr. Yang Guang, Mr. Zhou Xiang, and Mr. Wang Qicheng), they collectively hold about 17.57% of the company's total issued capital.
Related Articles

BOAN BIOTECH (06955) repurchased 1.5 million shares at a cost of approximately HKD 4.5537 million on September 8.

CICC (03908) plans to issue company bonds of no more than 6 billion yuan.

C-MER MEDICAL (03309) spent approximately HKD 170,200 to repurchase 200,000 shares on September 8.
BOAN BIOTECH (06955) repurchased 1.5 million shares at a cost of approximately HKD 4.5537 million on September 8.

CICC (03908) plans to issue company bonds of no more than 6 billion yuan.

C-MER MEDICAL (03309) spent approximately HKD 170,200 to repurchase 200,000 shares on September 8.

RECOMMEND





